March 13, 2025

Multivitamins After MI: Any Benefit for Patients with Diabetes?

The primary endpoint occurred in 35% of both the OMVM and placebo groups, according to a randomized trial evaluating multivitamins in post-MI patients with diabetes.

Conexiant

March 13, 2025

Sedentary Time and Anxiety: Walking’s Role in Risk Reduction

Researchers identified a J-shaped dose–response relationship, with minimal anxiety risk at six sedentary hours per day but a steep increase beyond this threshold, while walking for more than ten minutes on most days mitigated this effect.

Conexiant

March 13, 2025

Study Finds No Clear Evidence That Red Wine Mitigates Cancer Risk

Investigators evaluated the anticancer properties of red wine compared to white wine.

The ASCO Post

March 13, 2025

Combination Therapy Could Help Overcome Drug Resistance in Patients With KRAS-Mutated NSCLC

Although the FDA-approved drugs sotorasib and adagrasib have provided hope to some patients with non-small cell lung cancer (NSCLC) by targeting KRAS G12C, the majority of tumors either resist treatme...

The ASCO Post

March 13, 2025

Association of Pathogenic Variants With Cancer Mortality

Oncologists often encounter patients who have pathogenic variants in certain genes known to increase the risk of breast, pancreatic, and colorectal cancers. But do these same variants increase mortali...

The ASCO Post

March 13, 2025

In the Nick of Time

New research highlights the role smartwatches could play in infectious disease control

The Pathologist

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 13, 2025

Mediterranean Diet Associated With 51% Lower IBS Risk: Study

New research shows Mediterranean diet and PDQS adherence linked to significantly reduced odds of irritable bowel syndrome in case-control study

Conexiant

March 13, 2025

Meta-Analysis: Polyphenols' Role in Preeclampsia Uncertain

The addition of epigallocatechin gallate (EGCG) to nifedipine may reduce the time needed to achieve blood pressure control by 14.10 minutes (95% CI = −18.46 to −9.74), according to a new systematic review and meta-analysis published in BJOG.

Conexiant